Selective thromboxane synthase inhibition does not increase in vivo synthesis of prostacyclin in healthy humans. 1991

O Vesterqvist, and K Gréen, and P Henriksson, and G Rasmanis, and O Edhag
Department of Clinical Chemistry and Blood Coagulation, Karolinska Hospital, Stockholm, Sweden.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D008297 Male Males
D011464 Epoprostenol A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension (HYPERTENSION, PULMONARY). Prostacyclin,Prostaglandin I2,Epoprostanol,Epoprostenol Sodium,Epoprostenol Sodium Salt, (5Z,9alpha,11alpha,13E,15S)-Isomer,Flolan,Prostaglandin I(2),Veletri
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013928 Thromboxane A2 An unstable intermediate between the prostaglandin endoperoxides and thromboxane B2. The compound has a bicyclic oxaneoxetane structure. It is a potent inducer of platelet aggregation and causes vasoconstriction. It is the principal component of rabbit aorta contracting substance (RCS). Rabbit Aorta Contracting Substance,A2, Thromboxane
D013930 Thromboxane-A Synthase An enzyme found predominantly in platelet microsomes. It catalyzes the conversion of PGG(2) and PGH(2) (prostaglandin endoperoxides) to thromboxane A2. EC 5.3.99.5. Thromboxane Synthetase,Thromboxane A Synthase,Thromboxane A2 Synthetase,A2 Synthetase, Thromboxane,Synthase, Thromboxane A,Synthase, Thromboxane-A,Synthetase, Thromboxane,Synthetase, Thromboxane A2

Related Publications

O Vesterqvist, and K Gréen, and P Henriksson, and G Rasmanis, and O Edhag
September 1988, Scandinavian journal of clinical and laboratory investigation,
O Vesterqvist, and K Gréen, and P Henriksson, and G Rasmanis, and O Edhag
October 1983, The Journal of clinical investigation,
O Vesterqvist, and K Gréen, and P Henriksson, and G Rasmanis, and O Edhag
June 1985, The American journal of physiology,
O Vesterqvist, and K Gréen, and P Henriksson, and G Rasmanis, and O Edhag
January 1986, Scandinavian journal of haematology,
O Vesterqvist, and K Gréen, and P Henriksson, and G Rasmanis, and O Edhag
January 2007, Journal of cellular and molecular medicine,
O Vesterqvist, and K Gréen, and P Henriksson, and G Rasmanis, and O Edhag
March 1981, Prostaglandins,
O Vesterqvist, and K Gréen, and P Henriksson, and G Rasmanis, and O Edhag
January 1983, Prostaglandins,
O Vesterqvist, and K Gréen, and P Henriksson, and G Rasmanis, and O Edhag
July 1982, Lancet (London, England),
O Vesterqvist, and K Gréen, and P Henriksson, and G Rasmanis, and O Edhag
April 1991, Journal of cardiovascular pharmacology,
O Vesterqvist, and K Gréen, and P Henriksson, and G Rasmanis, and O Edhag
March 2004, American journal of physiology. Heart and circulatory physiology,
Copied contents to your clipboard!